AbbVie, Calibr to drive preclinical and clinical advancements in expanded partnership
AbbVie and Scripps Research institute’s division Calibr have announced a broadened strategic collaboration targeted at developing preclinical and early-stage clinical assets across a host of therapeutic areas such as immunology, oncology, and neuroscience. The extended partnership which aligns with AbbVie’s core areas of interest builds upon the company’s 2019 partnership with Scripps Research. Thomas Hudson, […]
